Literature DB >> 25514671

Cytokine expression provides clues to the pathophysiology of Gulf War illness and myalgic encephalomyelitis.

Svetlana F Khaiboullina1, Kenny L DeMeirleir2, Shanti Rawat2, Grady S Berk2, Rory S Gaynor-Berk3, Tatjana Mijatovic4, Natalia Blatt5, Albert A Rizvanov5, Sheila G Young3, Vincent C Lombardi6.   

Abstract

Gulf War illness (GWI) is a chronic disease of unknown etiology characterized by persistent symptoms such as cognitive impairment, unexplained fatigue, pervasive pain, headaches, and gastrointestinal abnormalities. Current reports suggest that as many as 200,000 veterans who served in the 1990-1991 Persian Gulf War were afflicted. Several potential triggers of GWI have been proposed including chemical exposure, toxins, vaccines, and unknown infectious agents. However, a definitive cause of GWI has not been identified and a specific biological marker that can consistently delineate the disease has not been defined. Myalgic encephalomyelitis (ME) is a disease with similar and overlapping symptomology, and subjects diagnosed with GWI typically fit the diagnostic criteria for ME. For these reasons, GWI is often considered a subgroup of ME. To explore this possibility and identify immune parameters that may help to understand GWI pathophysiology, we measured 77 serum cytokines in subjects with GWI and compared these data to that of subjects with ME as well as healthy controls. Our analysis identified a group of cytokines that identified ME and GWI cases with sensitivities of 92.5% and 64.9%, respectively. The five most significant cytokines in decreasing order of importance were IL-7, IL-4, TNF-α, IL-13, and IL-17F. When delineating GWI and ME cases from healthy controls, the observed specificity was only 33.3%, suggesting that with respect to cytokine expression, GWI cases resemble control subjects to a greater extent than ME cases across a number of parameters. These results imply that serum cytokines are representative of ME pathology to a greater extent than GWI and further suggest that the two diseases have distinct immune profiles despite their overlapping symptomology.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytokines; Gulf War illness; Myalgic encephalomyelitis; Random forest: interleukin-7

Mesh:

Substances:

Year:  2014        PMID: 25514671      PMCID: PMC4410698          DOI: 10.1016/j.cyto.2014.11.019

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  48 in total

Review 1.  Interleukin-7: from bench to clinic.

Authors:  Terry J Fry; Crystal L Mackall
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

Review 2.  Natural killer cells and natural killer cell activity in chronic fatigue syndrome.

Authors:  T L Whiteside; D Friberg
Journal:  Am J Med       Date:  1998-09-28       Impact factor: 4.965

3.  Chronic multisymptom illness affecting Air Force veterans of the Gulf War.

Authors:  K Fukuda; R Nisenbaum; G Stewart; W W Thompson; L Robin; R M Washko; D L Noah; D H Barrett; B Randall; B L Herwaldt; A C Mawle; W C Reeves
Journal:  JAMA       Date:  1998-09-16       Impact factor: 56.272

Review 4.  Plasmacytoid dendritic cells of the gut: relevance to immunity and pathology.

Authors:  Vincent C Lombardi; Svetlana F Khaiboullina
Journal:  Clin Immunol       Date:  2014-04-24       Impact factor: 3.969

5.  Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome.

Authors:  K Konstantinov; A von Mikecz; D Buchwald; J Jones; L Gerace; E M Tan
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

6.  Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin.

Authors:  Michael Maes; Frank N M Twisk; Marta Kubera; Karl Ringel
Journal:  J Affect Disord       Date:  2011-10-04       Impact factor: 4.839

7.  Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series.

Authors:  Øystein Fluge; Olav Mella
Journal:  BMC Neurol       Date:  2009-07-01       Impact factor: 2.474

8.  A comparison of sex-specific immune signatures in Gulf War illness and chronic fatigue syndrome.

Authors:  Anne Liese Smylie; Gordon Broderick; Henrique Fernandes; Shirin Razdan; Zachary Barnes; Fanny Collado; Connie Sol; Mary Ann Fletcher; Nancy Klimas
Journal:  BMC Immunol       Date:  2013-06-25       Impact factor: 3.615

9.  Plasma cytokines in women with chronic fatigue syndrome.

Authors:  Mary Ann Fletcher; Xiao Rong Zeng; Zachary Barnes; Silvina Levis; Nancy G Klimas
Journal:  J Transl Med       Date:  2009-11-12       Impact factor: 5.531

10.  Dissecting the psoriasis transcriptome: inflammatory- and cytokine-driven gene expression in lesions from 163 patients.

Authors:  William R Swindell; Andrew Johnston; John J Voorhees; James T Elder; Johann E Gudjonsson
Journal:  BMC Genomics       Date:  2013-08-01       Impact factor: 3.969

View more
  30 in total

1.  Genome-wide transcriptome architecture in a mouse model of Gulf War Illness.

Authors:  Fuyi Xu; David G Ashbrook; Jun Gao; Athena Starlard-Davenport; Wenyuan Zhao; Diane B Miller; James P O'Callaghan; Robert W Williams; Byron C Jones; Lu Lu
Journal:  Brain Behav Immun       Date:  2020-06-20       Impact factor: 7.217

2.  Pyridostigmine bromide and stress interact to impact immune function, cholinergic neurochemistry and behavior in a rat model of Gulf War Illness.

Authors:  V A Macht; J L Woodruff; E S Maissy; C A Grillo; M A Wilson; J R Fadel; L P Reagan
Journal:  Brain Behav Immun       Date:  2019-04-03       Impact factor: 7.217

3.  Alterations in high-order diffusion imaging in veterans with Gulf War Illness is associated with chemical weapons exposure and mild traumatic brain injury.

Authors:  Chia-Hsin Cheng; Bang-Bon Koo; Samantha Calderazzo; Emily Quinn; Kristina Aenlle; Lea Steele; Nancy Klimas; Maxine Krengel; Patricia Janulewicz; Rosemary Toomey; Lindsay T Michalovicz; Kimberly A Kelly; Timothy Heeren; Deborah Little; James P O'Callaghan; Kimberly Sullivan
Journal:  Brain Behav Immun       Date:  2020-07-31       Impact factor: 7.217

Review 4.  Gulf War Illness: Mechanisms Underlying Brain Dysfunction and Promising Therapeutic Strategies.

Authors:  Brandon Dickey; Leelavathi N Madhu; Ashok K Shetty
Journal:  Pharmacol Ther       Date:  2020-10-24       Impact factor: 12.310

Review 5.  Adaptive Immune Responses Associated with the Central Nervous System Pathology of Gulf War Illness.

Authors:  Aurore Nkiliza; Utsav Joshi; James E Evans; Ghania Ait-Ghezala; Megan Parks; Fiona Crawford; Michael Mullan; Laila Abdullah
Journal:  Neurosci Insights       Date:  2021-05-25

6.  Multiplex Analysis of Serum Cytokines in Humans with Hantavirus Pulmonary Syndrome.

Authors:  Sergey P Morzunov; Svetlana F Khaiboullina; Stephen St Jeor; Albert A Rizvanov; Vincent C Lombardi
Journal:  Front Immunol       Date:  2015-08-31       Impact factor: 7.561

7.  Dysregulation of Protein Kinase Gene Expression in NK Cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients.

Authors:  Anu Chacko; Donald R Staines; Samantha C Johnston; Sonya M Marshall-Gradisnik
Journal:  Gene Regul Syst Bio       Date:  2016-08-28

8.  Blood Biomarkers of Chronic Inflammation in Gulf War Illness.

Authors:  Gerhard J Johnson; Billie C S Slater; Linda A Leis; Thomas S Rector; Ronald R Bach
Journal:  PLoS One       Date:  2016-06-28       Impact factor: 3.240

9.  A Chronic Longitudinal Characterization of Neurobehavioral and Neuropathological Cognitive Impairment in a Mouse Model of Gulf War Agent Exposure.

Authors:  Zuchra Zakirova; Gogce Crynen; Samira Hassan; Laila Abdullah; Lauren Horne; Venkatarajan Mathura; Fiona Crawford; Ghania Ait-Ghezala
Journal:  Front Integr Neurosci       Date:  2016-01-12

10.  Circulating HMGB1 is elevated in veterans with Gulf War Illness and triggers the persistent pro-inflammatory microglia phenotype in male C57Bl/6J mice.

Authors:  Carla Garza-Lombó; Morrent Thang; Hendrik J Greve; Christen L Mumaw; Evan J Messenger; Chandrama Ahmed; Emily Quinn; Kimberly Sullivan; Michelle L Block
Journal:  Transl Psychiatry       Date:  2021-07-12       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.